Moneycontrol
HomeNewsBusinessBharatmala project may face delays of around six years, says ICRA
Trending Topics

Bharatmala project may face delays of around six years, says ICRA

According to ICRA, if the Indian government manages to execute around 4,500-5,000 km of projects under the Bharatmala scheme, all projects will be completed by 2027-28.

July 18, 2022 / 16:39 IST
Story continues below Advertisement
Picture for representation (Image: Pexels)

Rating agency ICRA on July 18 said that the government’s road connectivity project under the 'Bharatmala Pariyojana' program may face delays of around six years and will be completed only by 2027-28.

Story continues below Advertisement

According to ICRA, if the Indian government manages to execute around 4,500-5,000 km of projects under the Bharatmala scheme, all projects will be completed by 2027-28.

Announced in July 2015, the Bharatmala project involves the development of 24,800 km of national highways and a residual 10,000 km of highways pending under the erstwhile National Highway Development Program (NHDP) by 2021-22, at an estimated outlay of Rs. 5.35 trillion.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show